Cited by 5,204Epilepsy research and treatmentPharmacological Effects and Toxicity StudiesDiet and metabolism studies

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Early Identification of Refractory Epilepsy

Open access

Kwan, Patrick, Brodie, Martin J.·2000·New England Journal of Medicine

DOI 10.1056/nejm200002033420503

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: More than 30 percent of patients with epilepsy have inadequate control of seizures with drug therapy, but why this happens and whether it can be predicted are unknown. We studied the response to antiepileptic drugs in patients with newly diagnosed epilepsy to identify factors associated with subsequent poor control of seizures. METHODS: We prospectively studied 525 patients (age, 9 to 93 years) who were given a diagnosis, treated, and followed up at a single center between 1984 and 1997. Epilepsy was classified as idiopathic (with a presumed genetic basis), symptomatic (resulting from a structural abnormality), or cryptogenic (resulting from an unknown underlying cause). Patients were considered to be seizure-free if they had not had any seizures for at least one year. RESULTS: Among the 525 patients, 333 (63 percent) remained seizure-free during antiepileptic-drug treatment or after treatment was stopped. The prevalence of persistent seizures was higher in patients with symptomatic or cryptogenic epilepsy than in those with idiopathic epilepsy (40 percent vs. 26 percent, P=0.004) and in patients who had had more than 20 seizures before starting treatment than in those who had had fewer (51 percent vs. 29 percent, P<0.001). The seizure-free rate was similar in patients who were treated with a single established drug (67 percent) and patients who were treated with a single new drug (69 percent). Among 470 previously untreated patients, 222 (47 percent) became seizure-free during treatment with their first antiepileptic drug and 67 (14 percent) became seizure-free during treatment with a second or third drug. In 12 patients (3 percent) epilepsy was controlled by treatment with two drugs. Among patients who had no response to the first drug, the percentage who subsequently became seizure-free was smaller (11 percent) when treatment failure was due to lack of efficacy than when it was due to intolerable side effects (41 percent) or an idiosyncratic reaction (55 percent). CONCLUSIONS: Patients who have many seizures before therapy or who have an inadequate response to initial treatment with antiepileptic drugs are likely to have refractory epilepsy.

Integrity signals

Registry

Crossref · 10.1056/nejm200002033420503

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Proposal for Revised Classification of Epilepsies and Epileptic Syndromes: Commission on Classification and Terminology of the International League Against Epilepsy
(1989) · Epilepsia · doi:10.1111/j.1528-1157.1989.tb05316.x · Cited by 5,347
Guidelines for Epidemiologic Studies on Epilepsy
(1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb00433.x · Cited by 1,360
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
Semah, F., Picot, M., Adam, C., Broglin, D., Arzimanoglou, A. A., Bazin, B., Cavalcanti, D., & Baulac, M. (1998) · Neurology · doi:10.1212/wnl.51.5.1256 · Cited by 1,105
Surgery for Seizures
Engel, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603073341008 · Cited by 880
Long-Term Prognosis of Seizures with Onset in Childhood
Sillanpää, M. L., Jalava, M., Kaleva, O., & Shinnar, S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806113382402 · Cited by 725
Remission of Seizures and Relapse in Patients with Epilepsy
Annegers, J. F., Hauser, W. A., & Elveback, L. R. (1979) · Epilepsia · doi:10.1111/j.1528-1157.1979.tb04857.x · Cited by 621
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
Brodie, M. J., UK Lamotrigine/Carbamazepine Monotherapy Trial Group, Richens, A., & Yuen, A. W. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90581-2 · Cited by 614
Self-citation
MDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy
Tishler, D. M., Weinberg, K. I., Hinton, D. R., Barbaro, N. M., Annett, G., & Raffel, C. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01657.x · Cited by 529
Multidrug resistance: molecular mechanisms and clinical relevance
Ling, V. W. T. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051053 · Cited by 525
Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy
Brodie, M. J., Overstall, P. W., & Giorgi, L. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(99)00039-x · Cited by 462
Self-citation

Show all 39 references

Research works printed but not linked: 2

Dreifuss FE. Classification of epileptic seizures. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998:517-24.
Wolf P. International classification of the epilepsies. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998:773-7.

Sorted by citations

Items 601–700 of 1,005

Pharmacoresistant Epilepsy: A Current Update on Non-Conventional Pharmacological and Non-Pharmacological Interventions
Sharma, A. K., Rani, E., Waheed, A., & Rajput, S. K. (2015) · Journal of Epilepsy Research · doi:10.14581/jer.15001 · Cited by 74
Should enzyme‐inducing antiepileptic drugs be considered first‐line agents?
Mintzer, S., & Mattson, R. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02235.x · Cited by 74
Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats
Reeta, K. H., Mehla, J., Pahuja, M., & Gupta, Y. K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.05.011 · Cited by 74
Pathophysiological Mechanisms of Focal Cortical Dysplasia: A Critical Review of Human Tissue Studies and Animal Models
Najm, I., Tilelli, C. Q., & Oghlakian, R. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01064.x · Cited by 74
A Greater Role for Surgical Treatment of Epilepsy: Why and When?
Engel, J. (2003) · Epiliepsy currents/Epilepsy currents · doi:10.1046/j.1535-7597.2003.03201.x · Cited by 74
Cognitive effects of pregabalin in healthy volunteers
Salinsky, M., Storzbach, D. M., & Munoz, S. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d25b34 · Cited by 74
A study of drug-resistant childhood epilepsy testing the new ILAE criteria
Lizana, J. R., Rodriguez-Lucenilla, M. I., Aguilera-López, P., Aguirre-Rodríguez, J., & Cassinello-García, E. (2012) · Seizure · doi:10.1016/j.seizure.2012.01.009 · Cited by 73
Clinical efficacy of deep brain stimulation for the treatment of medically refractory epilepsy
Klinger, N. V., & Mittal, S. (2015) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2015.11.009 · Cited by 73
Refractory Epilepsy: One Size Does Not Fit All
French, J. A. (2006) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7511.2006.00137.x · Cited by 73
GABAB Receptors, Schizophrenia and Sleep Dysfunction
Kantrowitz, J. T., Citrome, L., & Javitt, D. C. (2009) · CNS Drugs · doi:10.2165/00023210-200923080-00005 · Cited by 73
Rational Polytherapy with Antiepileptic Drugs
Lee, J. W., & Dworetzky, B. A. (2010) · Pharmaceuticals · doi:10.3390/ph3082362 · Cited by 74
No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population
Lakhan, R., Misra, U. K., Kalita, J., Pradhan, S., Gogtay, N., Singh, M. K., & Mittal, B. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.08.019 · Cited by 73
Parent health literacy and adherence-related outcomes in children with epilepsy
Paschal, A. M., Mitchell, Q. P., Wilroy, J., Hawley, S. R., & Mitchell, J. B. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.12.036 · Cited by 74
Quality‐of‐life aspects in idiopathic epilepsy in dogs
Wessmann, A., Volk, H. A., Packer, R. M. A., Ortega, M. D. C. A., & Anderson, T. J. (2016) · Veterinary Record · doi:10.1136/vr.103355 · Cited by 73
Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats
Srivastava, A. K., & White, H. S. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.10.003 · Cited by 72
7T MRI in epilepsy patients with previously normal clinical MRI exams compared against healthy controls
Feldman, R. E., Delman, B. N., Pawha, P., Dyvorne, H., Rutland, J. W., Yoo, J. Y., Fields, M. C., Marcuse, L. V., & Balchandani, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213642 · Cited by 72
What has been the impact of new drug treatments on epilepsy?
Chen, Z. Z., Brodie, M. J., & Kwan, P. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000803 · Cited by 73
Self-citation
The Potential of Pregabalin in Neurology, Psychiatry and Addiction: A Qualitative Overview
Martinotti, G., Lupi, M., Sarchione, F., Santacroce, R., Salone, A., Berardis, D. D., Serroni, N., Cavuto, M., Signorelli, M. S., Aguglia, E., et al. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990425 · Cited by 72
Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy
Helmers, S. L., Duh, M. S., Guérin, A., Sarda, S. P., Samuelson, T. M., Bunker, M. T., Olin, B., Jackson, S. D., & Faught, E. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.07.020 · Cited by 72
Mapping preictal and ictal haemodynamic networks using video-electroencephalography and functional imaging
Chaudhary, U. J., Carmichael, D. W., Rodionov, R., Thornton, R. C., Bartlett, P., Vulliémoz, S., Micallef, C., McEvoy, A. W., Diehl, B., Walker, M. C., et al. (2012) · Brain · doi:10.1093/brain/aws302 · Cited by 71
Remission of Seizures in a Population‐Based Adult Cohort with a Newly Diagnosed Unprovoked Epileptic Seizure
Lindsten, H., Stenlund, H. C., & Forsgren, L. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.0420081025.x · Cited by 72
The medical management of the epilepsies in children: conceptual and practical considerations
Raspall‐Chaure, M., Neville, B. G. R., & Scott, R. C. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70324-1 · Cited by 75
P2X7 receptor antagonism reduces the severity of spontaneous seizures in a chronic model of temporal lobe epilepsy.
Amhaoul, H., Ali, I., Mola, M., Eetveldt, A. V., Szewczyk, K., Missault, S., Bielen, K., Kumar-Singh, S., Rech, J., Lord, B., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.018 · Cited by 67
The Early Identification of Candidates for Epilepsy Surgery
Dlugos, D. (2001) · Archives of Neurology · doi:10.1001/archneur.58.10.1543 · Cited by 72
Network, clinical and sociodemographic features of cognitive phenotypes in temporal lobe epilepsy
Hermann, B. P., Conant, L. L., Cook, C. J., Hwang, G., Garcia‐Ramos, C., Dabbs, K., Nair, V. A., Mathis, J. R., Rivera-Bonet, C. N., Allen, L., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102341 · Cited by 71
The ups and downs of alkyl‐carbamates in epilepsy therapy: How does cenobamate differ?
Löscher, W., Sills, G. J., & White, H. S. (2021) · Epilepsia · doi:10.1111/epi.16832 · Cited by 71
Medically refractory epilepsy in autism
Sansa, G., Carlson, C., Doyle, W., Weiner, H. L., Bluvstein, J., Barr, W., & Devinsky, O. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03069.x · Cited by 71
Interictal diffusion MRI in partial epilepsies explored with intracerebral electrodes
Thivard, L., Adam, C., Hasboun, D., Clémenceau, S., Dezamis, E., Lehéricy, S., Dormont, D., Jacques Chiras, C., Baulac, M., & Dupont, S. (2005) · Brain · doi:10.1093/brain/awh709 · Cited by 71
Down-regulation Synaptic Vesicle Protein 2A in the Anterior Temporal Neocortex of Patients with Intractable Epilepsy
Feng, G., Xiao, F., Lü, Y., Huang, Z., Yuan, J., Xiao, Z., Xi, Z., & Wang, X. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9288-2 · Cited by 71
Early versus late remission in a cohort of patients with newly diagnosed epilepsy
Felice, A. D., Beghi, E., Boero, G., Neve, A. L., Bogliun, G., Palo, A. D., & Specchio, L. M. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02141.x · Cited by 71
Approach to pediatric epilepsy surgery: State of the art, Part I: General principles and presurgical workup
Obeid, M., Wyllie, E., Rahi, A. C., & Mikati, M. A. (2008) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2008.05.007 · Cited by 71
Two-stage genome-wide association study identifies variants in CAMSAP1L1 as susceptibility loci for epilepsy in Chinese
Guo, Y., Baum, L., Sham, P. C., Wong, V. C. N., Ng, P. W., Lui, C. H. T., Sin, N. C., Tsoi, T. H., Tang, C. S.-M., Kwan, J. S. H., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr550 · Cited by 71
Self-citation
When drugs don’t work
Benbadis, S. R., Tatum, W. O., & Vale, A. (2000) · Neurology · doi:10.1212/wnl.55.12.1780 · Cited by 71
Current and Emerging Potential of Magnetoencephalography in the Detection and Localization of High-Frequency Oscillations in Epilepsy
Tamilia, E., Madsen, J., Grant, P., Pearl, P., & Papadelis, C. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00014 · Cited by 67
Strategies for surgical treatment of epilepsies in developing countries
Asadi‐Pooya, A. A., & Sperling, M. R. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01383.x · Cited by 70
Minimum standards for inpatient long-term video-EEG monitoring: A clinical practice guideline of the international league against epilepsy and international federation of clinical neurophysiology
Tatum, W. O., Mani, J., Jin, K., Halford, J. J., Gloss, D. S., Fahoum, F., Maillard, L. G., Mothersill, I. W., & Beniczky, S. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2021.07.016 · Cited by 76
Epilepsy and Cognitive Impairment in Childhood and Adolescence: A Mini-Review
Operto, F. F., Pastorino, G. M. G., Viggiano, A., Dell’Isola, G. B., Dini, G., Verrotti, A., & Coppola, G. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220706102708 · Cited by 76
“Despite numerous advances in the diagnosis and treat-ment of epilepsy, almost 30% of patients still do not respond to conventional therapy [83, 84].”
Background
Seizures and syncope:
Britton, J. W., & Benarroch, E. E. (2006) · Clinical Autonomic Research · doi:10.1007/s10286-006-0277-z · Cited by 70
Seizure detection using EEG and ECG signals for computer-based monitoring, analysis and management of epileptic patients
Mporas, I., Tsirka, V., Zacharaki, E. I., Koutroumanidis, M., Richardson, M. P., & Megalooikonomou, V. (2014) · Expert Systems with Applications · doi:10.1016/j.eswa.2014.12.009 · Cited by 70
Perampanel, an AMPA receptor antagonist: From clinical research to practice in clinical settings
Tsai, J.-J., Wu, T., Leung, H., Desudchit, T., Tiamkao, S., Lim, K. S., & Dash, A. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12879 · Cited by 70
Diagnosis and Surgical Treatment of Drug-Resistant Epilepsy
Anyanwu, C., & Motamedi, G. K. (2018) · Brain Sciences · doi:10.3390/brainsci8040049 · Cited by 71
Seizure-induced neuronal death in the immature brain
Wasterlain, C. G., Niquet, J., Thompson, K. W., Baldwin, R. A., Liu, H., Sankar, R., Mazarati, A. M., Naylor, D. E., Katsumori, H., Suchomelová, L., et al. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)35031-3 · Cited by 70
Management of a First Seizure
Bergey, G. K. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000271 · Cited by 70
Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety
Lattanzi, S., Brigo, F., Trinka, E., Zaccara, G., Striano, P., Giovane, C. D., & Silvestrini, M. (2020) · CNS Drugs · doi:10.1007/s40263-020-00708-6 · Cited by 71
Hilbert Vibration Decomposition-based epileptic seizure prediction with neural network
Büyükçakır, B., Elmaz, F., & Mutlu, A. Y. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.103665 · Cited by 69
Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis
Lattanzi, S., Trinka, E., Zaccara, G., Striano, P., Giovane, C. D., Silvestrini, M., & Brigo, F. (2020) · CNS Drugs · doi:10.1007/s40263-020-00759-9 · Cited by 69
Concept of epilepsy surgery and presurgical evaluation
Rathore, C., & Radhakrishnan, K. (2015) · Epileptic Disorders · doi:10.1684/epd.2014.0720 · Cited by 69
Synthesis and anticonvulsant activity of new phenytoin derivatives
Botros, S., Khalil, N. A., Naguib, B. H., & El‐Dash, Y. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.11.025 · Cited by 69
Antiepileptic drug response in temporal lobe epilepsy
Bilevicius, E., Yasuda, C. L., Silva, M. S., Guerreiro, C. A. M., Lopes‐Cendes, Í., & Cendes, F. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fc29dd · Cited by 69
Disparities in epilepsy surgery in the United States of America
Fernández, I. S., Stephen, C. D., & Loddenkemper, T. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8560-6 · Cited by 70
Antiepileptic drugs: evolution of our knowledge and changes in drug trials
Perucca, E. (2019) · Epileptic Disorders · doi:10.1684/epd.2019.1083 · Cited by 69
Seizure reporting technologies for epilepsy treatment: A review of clinical information needs and supporting technologies
Bidwell, J., Khuwatsamrit, T., Askew, B., Ehrenberg, J. A., & Helmers, S. L. (2015) · Seizure · doi:10.1016/j.seizure.2015.09.006 · Cited by 68
Adjunctive perampanel in adolescents with inadequately controlled partial‐onset seizures: A randomized study evaluating behavior, efficacy, and safety
Lagae, L. G., Villanueva, V., Meador, K. J., Bagul, M., Laurenza, A., Kumar, D., & Yang, H. (2016) · Epilepsia · doi:10.1111/epi.13417 · Cited by 68
Stereoelectroencephalography in epilepsy, cognitive neurophysiology, and psychiatric disease: safety, efficacy, and place in therapy
Youngerman, B. E., Khan, F. A., & McKhann, G. M. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s177804 · Cited by 73
Autoimmune epilepsy
Greco, A., Rizzo, M. I., VIRGILIO, A. D., Conte, M., Gallo, A., Attanasio, G., Ruoppolo, G., & VINCENTIIS, M. D. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.11.007 · Cited by 68
Valerenic acid and Valeriana officinalis extracts delay onset of Pentylenetetrazole (PTZ)-Induced seizures in adult Danio rerio (Zebrafish)
Torres-Hernández, B. A., Valle-Mojica, L. M. D., & Ortíz, J. G. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0731-3 · Cited by 68
Childhood Epilepsy: What Is the Evidence for What We Think and What We Do?
CAMFIELD, P. R., & Camfield, C. (2003) · Journal of Child Neurology · doi:10.1177/08830738030180041401 · Cited by 68
Combining ESI, ASL and PET for quantitative assessment of drug-resistant focal epilepsy
Storti, S. F., Galazzo, I. B., Felice, A. D., Pizzini, F. B., Arcaro, C., Formaggio, E., Mai, R., & Manganotti, P. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.06.028 · Cited by 68
Discovery of Heterocyclic Nonacetamide Synaptic Vesicle Protein 2A (SV2A) Ligands with Single‐Digit Nanomolar Potency: Opening Avenues towards the First SV2A Positron Emission Tomography (PET) Ligands
Mercier, J., Archen, L., Bollu, V., Carré, S., Evrard, Y., Jnoff, E., Kenda, B., Lallemand, B., Michel, P., Montel, F., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300482 · Cited by 68
Surgery for epilepsy: a systematic review of current evidence
West, S., Nevitt, S. J., & Newton, R. (2016) · Epileptic Disorders · doi:10.1684/epd.2016.0825 · Cited by 68
The current status of artisanal cannabis for the treatment of epilepsy in the United States
Sulak, D., Saneto, R. P., & Goldstein, B. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.12.032 · Cited by 69
Postlesional Epilepsy: The Ultimate Brain Plasticity
Jacobs, K. M., Graber, K., Kharazia, V., Parada, I., & Prince, D. A. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb01574.x · Cited by 68
Conference
Löscher, W., & Schmidt, D. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2004.06.004 · Cited by 69
A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers
Finnema, S. J., Rossano, S., Naganawa, M., Henry, S., Gao, H., Pracitto, R., Maguire, R. P., Mercier, J., Kervyn, S., Nicolas, J., et al. (2019) · Epilepsia · doi:10.1111/epi.14701 · Cited by 65
Epilepsy and the new cytogenetics
Mulley, J. C., & Mefford, H. C. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02932.x · Cited by 67
Epileptic-network-based prediction and control of seizures in humans
Lehnertz, K., Bröhl, T., & von Wrede, R. D. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106098 · Cited by 68
“Basic epilepsy treatment in almost all types of epilepsies is a pharmaceutical intervention by daily orally administered antiseizure medication (ASM) (Glauser et al., 2006).”
BackgroundInfluential
Dietary Treatment of Intractable Epilepsy
Cervenka, M. C., & Kossoff, E. H. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000431396.23852.56 · Cited by 67
Patient beliefs about epilepsy and brain surgery in a multicultural urban population
Prus, N., & Grant, A. C. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.09.022 · Cited by 67
Cross-sectional study of the prehospital management of adult patients with a suspected seizure (EPIC1)
Dickson, J. M., Taylor, L. H., Shewan, J., Baldwin, T., Grünewald, R. A., & Reuber, M. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010573 · Cited by 69
Thalamo–cortical network underlying deep brain stimulation of centromedian thalamic nuclei in intractable epilepsy: a multimodal imaging analysis
Kim, S., Lim, S. C., Yang, D. W., Cho, J. H., Son, B.-C., Kim, J., Hong, S. B., & Shon, Y. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s148617 · Cited by 67
Affiliate stigma and caregiver burden in intractable epilepsy
Hansen, B., Szaflarski, M., Bebin, E. M., & Szaflarski, J. P. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.05.028 · Cited by 67
Reversible psychiatric adverse effects related to deep brain stimulation of the anterior thalamus in patients with refractory epilepsy
Järvenpää, S., Peltola, J., Rainesalo, S., Leinonen, E. V. J., Lehtimäki, K. A., & Järventausta, K. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.09.006 · Cited by 67
Prognostic Significance of Failure of the Initial Antiepileptic Drug in Children with Absence Epilepsy
Wirrell, E. C., Camfield, C., CAMFIELD, P. R., & Dooley, J. M. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.02401.x · Cited by 67
Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study
Kwan, P., Sills, G. J., Kelly, K., Butler, E., & Brodie, M. J. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(00)00180-7 · Cited by 67
Self-citation
The Anti-Inflammatory Properties of Mesenchymal Stem Cells in Epilepsy: Possible Treatments and Future Perspectives
Salari, V., Mengoni, F., Gallo, F. D., Bertini, G., & Fabene, P. F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249683 · Cited by 66
Suppression of hippocampal epileptic seizures in the kainate rat by Poisson distributed stimulation
Wyckhuys, T., Boon, P., Raedt, R., Nieuwenhuyse, B. V., Vonck, K. E. J., & Wadman, W. J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02750.x · Cited by 66
Properties of human brain sodium channel α‐subunits expressed in HEK293 cells and their modulation by carbamazepine, phenytoin and lamotrigine
Qiao, X., Sun, G., Clare, J. J., Werkman, T. R., & Wadman, W. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12534 · Cited by 66
Research priorities in epilepsy for the next decade—A representative view of the European scientific community: Summary of the ILAE Epilepsy Research Workshop, Brussels, 17–18 January 2008
Baulac, M., & Pitkänen, A. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01811.x · Cited by 66
Sucrose consumption test reveals pharmacoresistant depression-associated behavior in two mouse models of temporal lobe epilepsy
Klein, S., Bankstahl, J. P., Löscher, W., & Bankstahl, M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.09.004 · Cited by 66
Prioritizing children's medicines for research: a pharmacoepidemiological study of antiepileptic drugs
Ackers, R., Murray, M. L., Besag, F., & Wong, I. C. K. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02842.x · Cited by 66
Predictors of Intractable Childhood Epilepsy
Yılmaz, B. Ş., Okuyaz, Ç., & Kömür, M. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2012.09.008 · Cited by 66
Transplant of GABAergic Precursors Restores Hippocampal Inhibitory Function in a Mouse Model of Seizure Susceptibility
Zipančić, I., Calcagnotto, M. E., Piquer‐Gil, M., Mello, L. E., & Álvarez‐Dolado, M. (2010) · Cell Transplantation · doi:10.3727/096368910x491383 · Cited by 66
Socioeconomic status influences time to surgery and surgical outcome in pediatric epilepsy surgery
Rubinger, L., Chan, C., Andrade, D. M., Go, C., Smith, M. L., Snead, O. C., Rutka, J. T., & Widjaja, E. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.12.007 · Cited by 66
Astroglial Scarring and Seizures
Robel, S. (2016) · The Neuroscientist · doi:10.1177/1073858416645498 · Cited by 64
Neurological Disorders
Thakur, K. T., Albanese, E., Giannakopoulos, P., Jetté, N., Linde, M., Prince, M. J., Steiner, T. J., & Dua, T. (2016) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0426-7_ch5 · Cited by 67
Disabling amnestic syndrome following stereotactic laser ablation of a hypothalamic hamartoma in a patient with a prior temporal lobectomy
Zubkov, S., Bene, V. A. D., MacAllister, W. S., Shepherd, T. M., & Devinsky, O. (2015) · Epilepsy & Behavior Case Reports · doi:10.1016/j.ebcr.2015.07.002 · Cited by 65
Anticonvulsant effect of unilateral anterior thalamic high frequency electrical stimulation on amygdala-kindled seizures in rat
Zhang, Q., Wu, Z., Yu, J., Zhong, X.-L., Xing, Y.-Y., Tian, Y., Miao, D., & Tan, L. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.023 · Cited by 65
Advances in genetic testing and optimization of clinical management in children and adults with epilepsy
Scala, M., Bianchi, A., Bisulli, F., Coppola, A., Elia, M., Trivisano, M., Pruna, D., Pippucci, T., Canafoglia, L., Lattanzi, S., et al. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1713101 · Cited by 63
Ketogenic therapy in neurodegenerative and psychiatric disorders: From mice to men
Kraeuter, A.-K., Phillips, R., & Sarnyai, Z. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109913 · Cited by 67
Brain stimulation treatments in epilepsy: Basic mechanisms and clinical advances
Foutz, T. J., & Wong, M. (2021) · Biomedical Journal · doi:10.1016/j.bj.2021.08.010 · Cited by 67
High Frequency Deep Brain Stimulation in the Hippocampus Modifies Seizure Characteristics in Kindled Rats
Wyckhuys, T., Smedt, T. D., Claeys, P., Raedt, R., Waterschoot, L., Vonck, K. E. J., den Broecke, C. V., Mabilde, C., Leybaert, L., Wadman, W. J., et al. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01038.x · Cited by 65
Functionalized nanocarrier combined seizure-specific vector with P-glycoprotein modulation property for antiepileptic drug delivery
Liu, J., He, Y., Zhang, J., Li, J., Yu, X., Cao, Z., Meng, F., Zhao, Y., Wu, X., Shen, T., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.09.041 · Cited by 66
Confusing placebo effect with natural history in epilepsy: A big data approach
Goldenholz, D. M., Moss, R., Scott, J. M., Auh, S., & Theodore, W. H. (2015) · Annals of Neurology · doi:10.1002/ana.24470 · Cited by 65
Predictors of refractory epilepsy in North India: A case–control study
Tripathi, M., Padhy, U. P., Vibha, D., Bhatia, R., Srivastava, M. V. P., Singh, M. B., Prasad, K., & Chandra, S. P. (2011) · Seizure · doi:10.1016/j.seizure.2011.07.010 · Cited by 65
Clinical Risk Factors Associated with Anti-Epileptic Drug Responsiveness in Canine Epilepsy
Packer, R. M. A., Shihab, N. K., Torres, B. B. J., & Volk, H. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106026 · Cited by 65
An evaluation of self-management behaviors and medication adherence in patients with epilepsy
McAuley, J. W., McFadden, L. S., Elliott, J. O., & Shneker, B. F. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.07.005 · Cited by 65
A critical period for prevention of posttraumatic neocortical hyperexcitability in rats
Graber, K., & Prince, D. A. (2004) · Annals of Neurology · doi:10.1002/ana.20124 · Cited by 65
Modeling Focal Epileptic Activity in the Wilson–Cowan Model with Depolarization Block
Meijer, H. G. E., Eissa, T. L., Kiewiet, B., Neuman, J., Schevon, C. A., Emerson, R. G., Goodman, R. R., McKhann, G. M., Marcuccilli, C. J., Tryba, A. K., et al. (2015) · The Journal of Mathematical Neuroscience · doi:10.1186/s13408-015-0019-4 · Cited by 62
Comparing neurostimulation technologies in refractory focal-onset epilepsy
Gooneratne, I. K., Green, A. L., Dugan, P. C., Sen, A., Franzini, A., Aziz, T. Z., & Cheeran, B. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-313297 · Cited by 65
A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target
Ibhazehiebo, K., Gavrilovici, C., de la Hoz, C. L. R., Ma, S., Rehak, R., Kaushik, G., Santoscoy, P. L. M., Scott, L. O. M., Nath, N. N., ‍Kim, D. Y., et al. (2018) · Brain · doi:10.1093/brain/awx364 · Cited by 64

Authors: Kwan, P., & Brodie, M. J.
Affiliations: Western Infirmary (GB)
ORCID: Kwan, Patrick
Brodie, Martin J.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2000-02-03
Volume: 342
Issue: 5
Pages: 314-319
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm200002033420503
OpenAlex: W1974809694
Cited by: 5,204
References: 39
Citations by year: 2026: 225 · 2025: 241 · 2024: 259 · 2023: 275 · 2022: 269 · 2021: 328 · 2020: 348 · 2019: 253 · 2018: 270 · 2017: 228 · 2016: 249 · 2015: 230 · 2014: 205 · 2013: 233 · 2012: 248
FWCI: 55.69
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
CRC Press eBooks (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
Keywords: drug-resistant epilepsy, antiepileptic drugs, seizure control, newly diagnosed epilepsy, idiopathic epilepsy, symptomatic epilepsy, cryptogenic epilepsy, seizure frequency, predictors of treatment failure, adverse drug reactions, polypharmacy
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Anticonvulsants, Child, Epilepsy, Female, Humans, Male, Middle Aged, Prospective Studies, Remission Induction, Treatment Failure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Early Identification of Refractory Epilepsy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks